John Paulson’s Q3 2025 13F portfolio surged to ~$2.97B, concentrated in just 10 securities, with Madrigal Pharma (MDGL) as the largest position. MDGL, now ~30% of the portfolio, was trimmed by ~9% but ...
James Chen, CMT is an expert trader, investment adviser, and global market strategist. Andy Smith is a Certified Financial Planner (CFP®), licensed realtor and educator with over 35 years of diverse ...
John Paulson's Paulson & Company 13F portfolio rose to ~$2.01B in Q2 2025, concentrated in 15 securities with top holdings in MDGL, PPTA, AAMI, BHC, and NG. Madrigal Pharma remains the largest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results